​

Ocuphire Pharma (OCUP) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Ocuphire Pharma Revenue Highlights

Latest Revenue (Y)

$19.05M

Latest Revenue (Q)

$1.11M

Ocuphire Pharma Revenue by Period

Ocuphire Pharma Revenue by Year

DateRevenueChange
2023-12-31$19.05M-52.20%
2022-12-31$39.85M6665.70%
2021-12-31$589.00K100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31--100.00%
2005-12-31$190.61K-

Ocuphire Pharma generated $19.05M in revenue during NA 2023, up -52.20% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Ocuphire Pharma Revenue by Quarter

DateRevenueChange
2024-06-30$1.11M-35.01%
2024-03-31$1.71M1.18%
2023-12-31$1.69M-85.83%
2023-09-30$11.94M224.85%
2023-06-30$3.67M110.06%
2023-03-31$1.75M-95.61%
2022-12-31$39.85M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$-589.00K-220.45%
2021-09-30$489.00K389.00%
2021-06-30$100.00K100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$1.15M100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-09-30--

Ocuphire Pharma generated $1.11M in revenue during Q2 2024, up -35.01% compared to the previous quarter, and up 63.58% compared to the same period a year ago.

Ocuphire Pharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RIGLRigel Pharmaceuticals$116.88M$55.31M
FBIOFortress Biotech$59.66M$14.63M
EYPTEyePoint Pharmaceuticals$46.02M$10.52M
CKPTCheckpoint Therapeutics$103.00K-
EYENEyenovia$3.79K$1.63K
MBIOMustang Bio--
RVPHReviva Pharmaceuticals--
CGTXCognition Therapeutics--
KODKodiak Sciences--
SLSSELLAS Life Sciences Group--
RNAZTransCode Therapeutics--

OCUP Revenue FAQ

What is Ocuphire Pharma’s yearly revenue?

Ocuphire Pharma's yearly revenue for 2023 was $19.05M, representing a decrease of -52.20% compared to 2022. The company's yearly revenue for 2022 was $39.85M, representing an increase of 6665.70% compared to 2021. OCUP's yearly revenue for 2021 was $589K, representing an increase of 100.00% compared to 2020.

What is Ocuphire Pharma’s quarterly revenue?

Ocuphire Pharma's quarterly revenue for Q2 2024 was $1.11M, a -35.01% decrease from the previous quarter (Q1 2024), and a -69.73% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.71M, a 1.18% increase from the previous quarter (Q4 2023), and a -2.17% decrease year-over-year (Q1 2023). OCUP's quarterly revenue for Q4 2023 was $1.69M, a -85.83% decrease from the previous quarter (Q3 2023), and a -95.76% decrease year-over-year (Q4 2022).

What is Ocuphire Pharma’s revenue growth rate?

Ocuphire Pharma's revenue growth rate for the last 3 years (2021-2023) was 3134.13%, and for the last 5 years (2019-2023) was 0%.